Solriamfetol (Sunosi, Jazz Pharmaceuticals) to treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea was approved on March 20, 2019.
Andrew J. Fratoni, PharmD and Kevin W. Chamberlin, PharmD
Advertisement
Articles by Andrew J. Fratoni, PharmD and Kevin W. Chamberlin, PharmD
Advertisement
Latest Updated Articles
Sunosi for Excessive Sleepiness in Adults with Narcolepsy or Obstructive Sleep ApneaPublished: January 20th 2020 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: Why Community Pharmacies are Displeased with the MDPNP | NCPA 2025
2
FDA Releases Biosimilar Guidance Pushing to Streamline Development
3
Pharmacies Should Prioritize Medicare Transaction Facilitator Enrollment | NCPA 2025
4
General Awareness of PBM Practices Driving Optimism for Independent Pharmacies | NCPA 2025
5
